400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR-INC-16009306
正在进行
美乐托宁
化药
美乐托宁
2016-10-03
/
卵巢储备功能下降
褪黑素联合DHEA治疗卵巢储备功能下降的临床试验
褪黑素联合DHEA治疗卵巢储备功能下降的临床试验
410008
The aim of the study is whether oral melatonin plus DHEA administration can improve the outcome of IVF in Diminished Ovarian Reserve (DOR) patients as follows: To determine embryological outcome; To determine biochemical outcome (to find out optimum hormono-microfollicular enviroment for high quality oocyte through comparing Melatonin, Estrogen, Progestrogen and LH in follicular fluidin leading follicles of different group patients including PCOS, Normal Ovarian Reserve, DOR patients with or without Melatonin plus DHEA treated).
横断面
治疗新技术
Randomization will be computerized.
/
中南大学湘雅医院生殖医学中心
/
50
/
2016-09-25
2017-02-27
/
For DOR patient: The criteria for DOR included AMH, FSH and Estradiol (E2) levels as well as antral follicle counts (AFC) or retrieved oocyte number. The patients were considered to have DOR if they have had serum AMH levels ≤ 1 ng/ml or an AFC≤5 on Day 3 of a spontaneous cycle or retrieved oocyte number ≤3. For NOR patient (Normal Ovarian Reserve): The criteria for Normal Ovarian Reserve (NOR) patients included AMH>3 ng/ml, FSH≤10 IU/ml, an AFC≥8 and or retrieved oocyte number ≥6. For PCOS patient: The criteria for PCOS patients included AMH>10 ng/ml, FSH/LH ratio >2, AFC for each ovaries ≥ 12(Total ≥ 25) and or retrieved oocyte number ≥ 15 or clinical and/or biochemical signs of hyperandrogenism.;
请登录查看The patients with known conditions affecting ovarian reserve, including ovarian surgery, polycystic ovarian syndrome, endometriosis, post chemo and radiation therapy recovery or BMI ≥ 25 will be excluded.;
请登录查看中南大学湘雅医院生殖医学中心
410008
浙江道尔生物科技有限公司2026-04-16
新药创始人2026-04-16
丁香园 Insight 数据库2026-04-16
2021至2023年理赔服务2026-04-16
干细胞与外泌体2026-04-16
细胞与基因治疗领域2026-04-16
北京药研汇2026-04-16
正大天晴药业集团2026-04-16
复融生物2026-04-16
先通医药2026-04-16